Skip to main content

Table 1 Demographic and clinical characteristics

From: Predicting the occurrence of multidrug-resistant organism colonization or infection in ICU patients: development and validation of a novel multivariate prediction model

 

Primary cohort (n = 331)

Validation cohort (n = 181)

Clinical characteristics

 Age, years

64.00 [52.00, 75.00]

56.00 [43.00, 69.00]

 Female, No (%)

125 (37.8)

45 (24.9)

 Previous hospitalization, No (%)

105 (31.7)

40 (22.1)

 Diabetes, No (%)

80 (24.2)

34 (18.8)

 Chronic lung disease, No (%)

32 (9.7)

17 (9.4)

 Chronic renal disease, No (%)

34 (10.3)

5 (2.8)

 Liver cirrhosis, No (%)

36 (10.9)

6 (3.3)

 Bulbar palsy, No (%)

8 (2.4)

7 (3.9)

 Immunosuppressive status, No (%)

41 (12.4)

8 (4.4)

 MDRO, No (%)

178 (53.8)

97 (53.6)

Organ function status

 Need of vasopressor agents, No (%)

101 (30.5)

55 (30.4)

 ALB, g/L

29.50 [25.80, 32.65]

29.00 [25.00, 34.00]

 TBil, umol/L

17.30 [9.10, 33.10]

18.40 [11.90, 25.00]

 PLT < 100 × 109/L, No (%)

98 (29.9)

33 (18.2)

 Cr, umol/L

76.00 [55.00, 135.50]

91.00 [65.00, 124.00]

 PaO2/FiO2, mmHg

224.00 [153.50, 305.50]

233.00 [175.00, 342.00]

Indwelling catheter

 Tracheal intubation / incision, No (%)

218 (65.9)

133 (73.5)

 Indwelling urethral catheter, No (%)

308 (93.1)

169 (93.4)

 Indwelling central venous catheter, No (%)

289 (87.3)

81 (44.8)

Laboratory indicators

 WBC, 109/L

11.96 [7.69, 17.43]

14.30 [11.70, 18.00]

 N%

87.50 [81.40, 91.90]

87.80 [83.90, 91.20]

 L%

6.10 [3.50, 10.90]

6.40 [4.50, 10.00]

 NLR

14.26 [7.61, 25.49]

13.61 [8.67, 19.80]

 PCT, ug/L

1.86 [0.46, 16.93]

0.38 [0.10, 2.46]

 CRP, mg/L

67.90 [24.00, 90.00]

98.10 [47.90, 169.50]

Scores

 SOFA

7.00 [4.00, 9.00]

7.00 [5.00, 9.00]

 APACHEII

14.00 [11.00, 18.50]

20.00 [14.00, 25.00]

 Pitt

2.00 [1.00, 4.50]

4.00 [2.00, 7.00]

  1. The quantitative data are normal distribution, expressed by mean ± standard deviation; The quantitative data were skewed and expressed in the median (25–75% percentile); Qualitative data were expressed in n%; MDRO multidrug-resistant organism; Alb albumin; TBil total bilirubin; PLT platelet; Cr creatinine; PaO2/FiO2, oxygenation index; WBC, leucocyte count; N%, neutrophil percentage; L%, lymphocyte percentage; NLR neutrophil-to-lymphocyte ratio; PCT procalcitionin; CRP, C- reactive protein; SOFA score, Sequential Organ Failure Assessment score; APACHEII score, Acute Physiology and Chronic Health Evaluation (APACHE) II score; Pitt score, Pitt bacteremia score